Suppliers / Kopran

Kopran

India 404 employees 2 duplicate records merged Updated 9 July 2026

Kopran is a contract manufacturer based in India. It appears in 129 regulatory filings across 10 regulators, without an active US DMF or CEP on file. Its filings concentrate with EFDA (ET), ZAMRA (ZM) and TMDA (TZ). Its GMP standing is certified by MHRA (UK) and EMA. Customs aggregates show $31.3M of exports covering 1,079 molecules to 30 destinations in 2025.

0
active US DMFs
0
valid CEPs
2
registered plants
129
filings across 10 regulators
These figures were checked against the regulators' own files on 25 July 2026
EU GMP
1 of 1 confirmed
Sources: EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.

Registered plants

Site FDA FEI
Mumbai, India Not on file
RAIGAD, India Not on file

Filings and GMP by regulator

Regulator Filings GMP certificates
EFDA (ET) 53 None
ZAMRA (ZM) 24 None
TMDA (TZ) 23 None
DIGEMAPS (DO) 10 None
ARCSA (EC) 9 None
MINSA (CR) 3 None
MHRA (UK) None 2
EMA None 1

Scale

Year Revenue Exports Destinations
2026 YTD Not reported $4.6M 16
2025 Not reported $31.3M 30
2024 Not reported $33.5M 27
2023 Not reported $32.3M 28

Export figures are customs aggregates. We do not publish the identity of any buyer.

Comparing suppliers?

Choose your molecules and target markets. Kopran comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates
Customs aggregates
Export values, molecule and destination counts